Published on PM360, April 2, 2018

The shift to value-based care and outcomes contracting type programs present the opportunity to align stakeholder interests around value and demonstrate a commitment to improving clinical and cost outcomes. From earlier detection to more precision management, the opportunities for pharma to partner around outcomes and value are growing. Win-wins for pharma and payers will come from expanding the conversation beyond the pill to the solution, such as aligning incentives and goals around data collection, use, and reporting; implementing care coordination, adherence, and other optimization tools; and leveraging predictive analytics or other risk reduction tools.

Read full article